Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07531043 Apraclonidine Hydrochloride Eye Redness Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07531043 clinical trial report covering Apraclonidine Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20261443 Benzoyl Peroxide/Tretinoin Acne Vulgaris Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
CTR20261443 clinical trial report covering Benzoyl Peroxide/Tretinoin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07533123 JSKN016 Triple Negative Breast Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07533123 clinical trial report covering JSKN016, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
ChiCTR2600122711 Teplizumab Diabetes Mellitus, Type 1 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
ChiCTR2600122711 clinical trial report covering Teplizumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07533175 Zenagamtide Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07533175 clinical trial report covering Zenagamtide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07533747 Empagliflozin Coronary microvascular dysfunction Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07533747 clinical trial report covering Empagliflozin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20261249 Compound Caraway Enteric Liquid Capsule Abdominal Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
CTR20261249 clinical trial report covering Compound Caraway Enteric Liquid Capsule, Phase 3, endpoints, sponsor, geography, readout timing and development
Read →
Latest Hotspot
8 min read
CTR20261254 Compound Caraway Enteric Liquid Capsule Abdominal Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
CTR20261254 clinical trial report covering Compound Caraway Enteric Liquid Capsule, Phase 3, endpoints, sponsor, geography, readout timing and development
Read →
Latest Hotspot
8 min read
NCT07537933 Tirofiban Hydrochloride Vascular occlusive disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07537933 clinical trial report covering Tirofiban Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07536373 Colchicine Chronic Limb-Threatening Ischemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07536373 clinical trial report covering Colchicine, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
JPRN-jRCT2011260002 Ramantamig Refractory Multiple Myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
JPRN-jRCT2011260002 clinical trial report covering Ramantamig, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07536763 Drospirenone/Estetrol Contraception Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07536763 clinical trial report covering Drospirenone/Estetrol, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
<
1
<<
79
80
81
82
83
>>
1586
>